Mast cell tumor screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guideline nam...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for mast cell tumor. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for mast cell tumor. | ||
==References== | ==References== | ||
Latest revision as of 20:28, 6 December 2018
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell tumor screening On the Web |
|
American Roentgen Ray Society Images of Mast cell tumor screening |
|
Risk calculators and risk factors for Mast cell tumor screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for mast cell tumor.
Screening
There is insufficient evidence to recommend routine screening for mast cell tumor.